Form 4: Clene Inc. Director Vallerie McLaughlin Granted Stock Options

Director Vallerie McLaughlin received stock options for 37,074 shares of Clene Inc. common stock on June 7, 2024.

Summary

• Vallerie McLaughlin, a director of Clene Inc., was granted stock options on June 7, 2024.
• The options are for 37,074 shares of Clene Inc. common stock.
• The exercise price is $0.37 per share.
• The options vest immediately upon grant and expire on June 6, 2034.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard transaction. The grant of options is neither particularly positive nor negative on its own.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• Immediate vesting may incentivize the director to contribute to the company's success.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with shareholder value.

Comparison to Industry Standards

• Stock option grants are a typical component of compensation packages for directors in publicly traded companies, particularly in the biotech sector.
• The size of the grant and vesting schedule would need to be compared to similar companies to assess its competitiveness.

Stakeholder Impact

• The stock option grant could potentially impact shareholders by diluting equity if the options are exercised.
• The grant may incentivize the director to work towards increasing shareholder value.

Key Dates